Terazosin

• Target :

  Others|||Adrenergic Receptor

• Related Pathways :

  Neuroscience|||Others|||GPCR/G Protein

• Bioactivity :

  Terazosin, a quinazoline derivative, is an orally active and competitive antagonist of ?1-adrenoceptors. Its mechanism of action involves relaxing blood vessels and promoting bladder opening. Terazosin exhibits therapeutic potential for treating benign prostatic hyperplasia (BPH) and high blood pressure [1][2][3].

• Smiles :

  NC=1C2=C(N=C(N1)N3CCN(C(=O)C4CCCO4)CC3)C=C(OC)C(OC)=C2

• Molecular Formula :

  C19H25N5O4

• Molecular Weight :

  387.43

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C

• CAS Number :

  63590-64-7